Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis.
Watanabe N, Kobayashi H, Hirama T, Kikuta A, Koizumi S, Tsuru T, Kaneko Y. Watanabe N, et al. Among authors: kobayashi h. Cancer Genet Cytogenet. 2002 Jul 1;136(1):10-6. doi: 10.1016/s0165-4608(02)00529-0. Cancer Genet Cytogenet. 2002. PMID: 12165445
Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neuroblastomas.
Tomioka N, Kobayashi H, Kageyama H, Ohira M, Nakamura Y, Sasaki F, Todo S, Nakagawara A, Kaneko Y. Tomioka N, et al. Among authors: kobayashi h. Genes Chromosomes Cancer. 2003 Feb;36(2):139-50. doi: 10.1002/gcc.10151. Genes Chromosomes Cancer. 2003. PMID: 12508242
Gilteritinib Monotherapy as a Transplant Bridging Option for a Patient with FLT3-Mutated Acute Promyelocytic Leukemia Who Developed a Second Relapse after All-Trans Retinoic Acid + Chemotherapy, Arsenic Trioxide, and High-Dose Cytarabine Therapy.
Kobayashi H, Tsutsumi H, Misaki Y, Maekawa T, Inoshita N, Kawamura M, Maseki N. Kobayashi H, et al. Case Rep Hematol. 2023 Dec 13;2023:8568587. doi: 10.1155/2023/8568587. eCollection 2023. Case Rep Hematol. 2023. PMID: 38124780 Free PMC article.
Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma.
Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Iizaki Y, Maseki N, Kawamura M, Kobayashi K, Nishimura Y, Kanda H, Nitta H, Noguchi M, Kobayashi H. Sekiguchi Y, et al. Among authors: kobayashi h, kobayashi k. J Clin Exp Hematop. 2023;63(4):262-265. doi: 10.3960/jslrt.23043. J Clin Exp Hematop. 2023. PMID: 38148017 Free PMC article. No abstract available.
A Case of Relapsed/Refractory CD56-Positive Acute Promyelocytic Leukemia, in Which Complete Molecular Remission Was Achieved Following Combination Therapy with Venetoclax and Azacitidine.
Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Maseki N, Iizaki Y, Kawamura M, Kobayashi K, Nitta H, Noguchi M, Wakita S, Yamaguchi H, Kobayashi H. Sekiguchi Y, et al. Among authors: kobayashi h, kobayashi k. Gan To Kagaku Ryoho. 2024 Mar;51(3):291-297. Gan To Kagaku Ryoho. 2024. PMID: 38494811
9,294 results